Koyfin Home > Directory > Health Care > Adma Biologics > Net Debt / (EBITDA-CAPEX)

Adma Biologics Net Debt / (EBITDA-CAPEX) Chart (ADMA)

Adma Biologics annual/quarterly Net Debt / (EBITDA-CAPEX) from 2010 to 2020.
  • Adma Biologics Net Debt / (EBITDA-CAPEX) for the quarter ending June 06, 2020 was $0m a -204.87% increase of 1m year over year
  • Adma Biologics Net Debt / (EBITDA-CAPEX) for the last 12 months ending June 06, 2020 was $0m a -71.35% increase of 0m year over year
  • Adma Biologics Annual Net Debt / (EBITDA-CAPEX) for 2019 was $-1m a 77.35% decrease of -1m from 2018
  • Adma Biologics Annual Net Debt / (EBITDA-CAPEX) for 2018 was $0m a 121.96% decrease of 0m from 2017
  • Adma Biologics Annual Net Debt / (EBITDA-CAPEX) for 2017 was $0m a 364.92% increase of 0m from 2016
Other Ratios Metrics:
  • Adma Biologics Total Debt / Capital for the quarter ending September 09, 2018 was $53m a 4.96% increase of 3m year over year
  • Adma Biologics Other Liabilities for the quarter ending December 12, 2018 was $18m a -0.86% decrease of 0m year over year
  • Adma Biologics Total Debt / Equity for the quarter ending September 09, 2018 was $111m a 9.91% increase of 11m year over year
View Chart On Koyfin

Quarterly ADMA Net Debt / (EBITDA-CAPEX) Data

06/2020$0m
03/2020$0m
12/2019$-2m
09/2019$-1m
06/2019$0m
03/2019$-1m
12/2018$0m
09/2018$0m
06/2018$0m
03/2018$0m

Annual ADMA Net Debt / (EBITDA-CAPEX) Data

2019$-1m
2018$0m
2017$0m
2016$0m
2015$0m
2014$0m
2013$2m
2012$1m
2011$0m
2010$-1m